Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

aTyr Pharma Names Chief Medical Officer

aTyr Pharma, a San Diego-based biotherapeutics company addressing  rare diseases, has appointed Sanjay Shukla as Chief Medical Officer. Shukla will lead aTyr’s clinical efforts to advance its Physiocrine biology therapeutic intervention points and develop medicines that promote tissue homeostasis for patients with rare diseases.

Read the full article…

Posted in Executive Appointments | Tagged , , | Leave a comment

M&A Continues to Dominate the Rare Diseases Landscape

Alexion took everyone by surprise in recent weeks by announcing a very sizable acquisition of Boston-based Synageva for $8.4bn. This was a significant deal which will only serve to strengthen valuations of rare disease biotechnology companies, which continue to be in the M&A cross-hairs of both pharmaceutical and big-biotech companies.

Read the full article…

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Sanofi appoint Chief Patient Officer

Authored by James Sheppard

Read the full article…

Posted in Executive Appointments, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , | Leave a comment

Novimmune sees immunotherapy and orphan focus attract new capital

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

New Enterprise Associates backs veteran rare diseases executive team

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Ultragenyx follows IPO with Board Appointments

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Dr Francois Nader – NPS Pharmaceuticals – Executive Leadership Series

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment

Mr David Mott – NEA – Executive Leadership Series

Authored by Karl Simpson

Read the full article…

Posted in Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment

Dr Flemming Ornskov – Shire – Executive Leadership Series

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

Jazz Pharmaceuticals to acquire rare disease company Gentium

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap